HomeBUSINESS
BUSINESS

Parkinson’s Disease Therapy Rasagiline Improves Average Daily Off-Time in Japan PII/PIII Study: Takeda
(Nov.1.2017)

Takeda Pharmaceutical said on October 30 that the Parkinson’s disease treatment rasagiline significantly improved the average daily off-time in Japanese Parkinson’s disease patients with the wearing-off-time phenomenon on the levodopa treatment in a PII/III clinical study ...
(LOG IN FOR FULL STORY)

News Calendar